StockData
Eupraxia Pharmaceuticals Inc. logo

Eupraxia Pharmaceuticals Inc. (EPRX) stock

EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 13, 2026Score 5/30
$6.21−0.41 (-6.19%)

Close on Nov 18, 2026Market cap $374.43MP/E –Yield –

Eupraxia Pharmaceuticals shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 40M, up 17.8% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202540M+17.8%
FY2024Dec 31, 202434M+40.5%
FY2023Dec 31, 202324M+25.2%
FY2022Dec 31, 202219M–

More Eupraxia Pharmaceuticals figures

See a number that looks wrong?